Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Leukemia ; 16(3): 352-61, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11896538

ABSTRACT

The immortalized murine stromal cell line AFT024 has been reported to maintain human hematopoietic progenitors in an undifferentiated state in vitro. In the current studies the beige/nude/xid (bnx) mouse in vivo xenograft model was used to examine the engraftment and multilineage generative potential of human hematopoietic progenitors after 2-3 weeks growth on AFT024 stroma, in comparison to primary stromal monolayers derived from post-natal human bone marrow. Eight to 12 months after transplantation of human CD34+CD38- cells from umbilical cord blood, cultured on AFT024 vs human stroma for 2-3 weeks, the murine bone marrow was harvested and analyzed for the presence of human myeloid and lymphoid cells. The mean percent engraftment of total human hematopoietic cells in the murine marrow was significantly higher after co-cultivation on AFT024 than on human stroma. Human myeloid and lymphoid lineage cells were detected in all mice. However, engraftment of myeloid lineage cells (CD33+), B lymphoid (CD19+), and T lymphoid cells (CD4+and CD8+) were significantly higher after co-cultivation of the human cells on AFT024 than on human stroma, prior to transplantation. Interestingly, the length of time in culture did not significantly affect the engraftment of the myeloid and T lymphoid lineage progenitors, but the percentage of B lymphoid lineage engraftment decreased significantly between 2 and 3 weeks of co-cultivation on both types of stroma. Cells with a primitive phenotype (CD45+/CD34-/CD38- and CD45+/CD34-/lin-) and cells with the capacity to generate secondary human CFU after recovery from the bnx bone marrow were maintained at significantly higher levels during culture on AFT024 stroma than on human stroma. The current studies demonstrate that the AFT024 murine stromal cell line supports the ex vivo survival and maintenance of human hematopoietic progenitors that are capable of long-term multilineage reconstitution for 2-3 weeks ex vivo, to levels superior to those that can be obtained using human stromal cells.


Subject(s)
Bone Marrow Transplantation/immunology , Hematopoiesis/immunology , Hematopoietic Stem Cell Transplantation , Hematopoietic Stem Cells/immunology , ADP-ribosyl Cyclase , ADP-ribosyl Cyclase 1 , Animals , Antigens, CD/blood , Antigens, Differentiation , B-Lymphocytes/immunology , Bone Marrow/immunology , Bone Marrow Cells , Cells, Cultured , Fetal Blood/cytology , Graft Survival , Humans , Immunophenotyping , Membrane Glycoproteins , Mice , Mice, SCID , NAD+ Nucleosidase , Stromal Cells/immunology , T-Lymphocytes/immunology , Transplantation, Heterologous
2.
J Immunol ; 167(4): 1867-70, 2001 Aug 15.
Article in English | MEDLINE | ID: mdl-11489963

ABSTRACT

Murine studies implicate Ikaros proteins as regulators of hemopoiesis, particularly in the lymphoid lineages. High homology between murine and human Ikaros suggests that Ikaros expression in the two might be similar. However, initial human studies that focused on leukemia detected novel Ikaros transcripts in patient samples. Thus, novel Ikaros splice forms and DNA nonbinding isoforms were linked with malignancy. We undertook an extensive analysis of normal human Ikaros expression to determine whether novel mRNAs are expressed as proteins and the extent to which these splice variants are unique to leukemia. Here we show that both mRNA and protein for DNA nonbinding Ikaros isoforms and splice variants previously linked to leukemia are expressed in normal human cells. However, our studies identify a new Ikaros isoform not previously described in mouse or human. This isoform is the predominant Ikaros protein in normal human cells, but not in leukemia cell lines.


Subject(s)
Hematopoietic Stem Cells/metabolism , Transcription Factors/biosynthesis , Bone Marrow Cells/immunology , Bone Marrow Cells/metabolism , Cells, Cultured , DNA-Binding Proteins/genetics , Fetal Blood/cytology , Fetal Blood/immunology , Fetal Blood/metabolism , Hematopoietic Stem Cells/immunology , Humans , Ikaros Transcription Factor , Jurkat Cells , Leukemia/immunology , Leukemia/metabolism , Mutagenesis, Insertional/immunology , Protein Isoforms/biosynthesis , Protein Isoforms/genetics , Protein Isoforms/metabolism , Sequence Deletion/immunology , Transcription Factors/genetics , Transcription Factors/metabolism , Transcription, Genetic/immunology , Tumor Cells, Cultured
3.
Blood ; 97(12): 3683-90, 2001 Jun 15.
Article in English | MEDLINE | ID: mdl-11389003

ABSTRACT

The earliest stages of lymphoid commitment from human pluripotent hematopoietic stem cells have not been defined. A clonogenic subpopulation of CD34(+)CD38(-) cord blood cells were identified that expressed high levels of the CD7 antigen and possessed only lymphoid potential. CD34(+)CD38(-)CD7(+) (CD7(+)) cells uniformly coexpressed CD45RA and HLA-DR; c-kit and Thy-1 expression was absent to low. Clonal analysis demonstrated that single CD7(+) cells could generate B cells, natural killer cells, and dendritic cells but were devoid of myeloid or erythroid potential. In contrast, control CD34(+)CD38(-)CD7(-) (CD7(-)) cells generated both lymphoid and myelo-erythroid cells. The lymphoid potential (generation of lymphoid progeny in bulk and single cell cultures) of CD7(+) cells was equivalent to that of the pluripotent CD7(-) cells. RNA expression studies showed that CD7(+) cells expressed PU.1 and GATA-3, but did not express Pax-5, terminal deoxynucleotide transferase, or CD3epsilon. In contrast to the previously described murine common lymphoid progenitor, the alpha chain of the receptor for interleukin-7 was not detected by fluorescence-activated cell sorting analysis or RNA polymerase chain reaction in CD7(+) cells. These studies identify a clonogenic lymphoid progenitor with both B-cell and natural killer cell lineage potential with a molecular profile that suggests a developmental stage more primitive than previously identified lymphoid progenitors. The CD7(+) phenotype distinguishes primitive human lymphoid progenitors from pluripotent stem cells, thus allowing the study of regulation of early human lymphopoiesis and providing an alternative to pluripotent stem cells for genetic manipulation and transplantation. (Blood. 2001;97:3683-3690)


Subject(s)
Antigens, CD , Cell Lineage , Fetal Blood/cytology , Hematopoietic Stem Cells/cytology , Lymphocyte Subsets/immunology , ADP-ribosyl Cyclase , ADP-ribosyl Cyclase 1 , Antigens, CD34/blood , Antigens, CD7/blood , Antigens, Differentiation/blood , B-Lymphocytes/cytology , Cell Differentiation , Clone Cells/cytology , Clone Cells/immunology , Dendritic Cells/cytology , Fetal Blood/immunology , Hematopoiesis , Hematopoietic Stem Cells/immunology , Humans , Immunophenotyping , Killer Cells, Natural/cytology , Lymphocytes/cytology , Membrane Glycoproteins , NAD+ Nucleosidase/blood , RNA, Messenger/analysis
4.
Mol Cell Biol ; 21(1): 260-70, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11113200

ABSTRACT

The cyclin-dependent kinase (CDK)-activating kinase (CAK) is involved in cell cycle control, transcription, and DNA repair (E. A. Nigg, Curr. Opin. Cell. Biol. 8:312-317, 1996). However, the mechanisms of how CAK is integrated into these signaling pathways remain unknown. We previously demonstrated that abrogation of MAT1 (ménage à trois 1), an assembly factor and targeting subunit of CAK, induces G(1) arrest (L. Wu, P. Chen, J. J. Hwang, L. W. Barsky, K. I. Weinberg, A. Jong, and V. A. Starnes, J. Biol. Chem. 274:5564-5572, 1999). This result led us to investigate how deregulation of CAK by MAT1 abrogation affects the cell cycle G(1) exit, a process that is regulated most closely by phosphorylation of retinoblastoma tumor suppressor protein (pRb). Using mammalian cellular models that undergo G(1) arrest evoked by antisense MAT1 abrogation, we found that deregulation of CAK inhibits pRb phosphorylation and cyclin E expression, CAK phosphorylation of pRb is MAT1 dose dependent but cyclin D1/CDK4 independent, and MAT1 interacts with pRb. These results suggest that CAK is involved in the regulation of cell cycle G(1) exit while MAT1-modulated CAK formation and CAK phosphorylation of pRb may determine the cell cycle specificity of CAK in G(1) progression.


Subject(s)
G1 Phase , Neoplasm Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Cell Division , Cyclin-Dependent Kinases/metabolism , Cyclins/metabolism , Gene Expression Regulation, Enzymologic , Humans , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/genetics , Phosphorylation , Protein Binding , Recombinant Fusion Proteins , Retinoblastoma Protein/metabolism , Substrate Specificity , Transduction, Genetic , Transfection , Tumor Cells, Cultured , Cyclin-Dependent Kinase-Activating Kinase
5.
J Immunol ; 165(5): 2382-9, 2000 Sep 01.
Article in English | MEDLINE | ID: mdl-10946261

ABSTRACT

The effect of IL-3 on the B lymphoid potential of human hemopoietic stem cells is controversial. Murine studies suggest that B cell differentiation from uncommitted progenitors is completely prevented after short-term exposure to IL-3. We studied B lymphopoiesis after IL-3 stimulation of uncommitted human CD34+CD38- cells, using the stromal cell line S17 to assay the B lymphoid potential of stimulated cells. In contrast to the murine studies, production of CD19+ B cells from human CD34+CD38- cells was significantly increased by a 3-day exposure to IL-3 (p < 0.001). IL-3, however, did not increase B lymphopoiesis from more mature progenitors (CD34+CD38+ cells) or from committed CD34-CD19+ B cells. B cell production was increased whether CD34+CD38- cells were stimulated with IL-3 during cocultivation on S17 stroma, on fibronectin, or in suspension. IL-3Ralpha expression was studied in CD34+ populations by RT-PCR and FACS. High IL-3Ralpha protein expression was largely restricted to myeloid progenitors. CD34+CD38- cells had low to undetectable levels of IL-3Ralpha by FACS. IL-3-responsive B lymphopoiesis was specifically found in CD34+ cells with low or undetectable IL-3Ralpha protein expression. IL-3 acted directly on progenitor cells; single cell analysis showed that short-term exposure of CD34+CD38- cells to IL-3 increased the subsequent cloning efficiency of B lymphoid and B lymphomyeloid progenitors. We conclude that short-term exposure to IL-3 significantly increases human B cell production by inducing proliferation and/or maintaining the survival of primitive human progenitors with B lymphoid potential.


Subject(s)
Antigens, CD34/biosynthesis , Antigens, CD , Antigens, Differentiation/biosynthesis , B-Lymphocyte Subsets/cytology , B-Lymphocyte Subsets/immunology , Hematopoietic Stem Cells/cytology , Hematopoietic Stem Cells/immunology , Interleukin-3/physiology , NAD+ Nucleosidase/biosynthesis , ADP-ribosyl Cyclase , ADP-ribosyl Cyclase 1 , Adjuvants, Immunologic/physiology , Antigens, CD19/biosynthesis , B-Lymphocyte Subsets/metabolism , Cell Culture Techniques , Cell Differentiation/immunology , Cells, Cultured , Child , Child, Preschool , Drug Combinations , Hematopoietic Stem Cells/metabolism , Humans , Interleukin-7/physiology , Ligands , Membrane Glycoproteins , Membrane Proteins/physiology , Stromal Cells/immunology , Time Factors
6.
Blood ; 94(11): 3872-82, 1999 Dec 01.
Article in English | MEDLINE | ID: mdl-10572103

ABSTRACT

Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia, eczema, and a progressive deterioration of immune function. WAS is caused by mutations in an intracellular protein, WASP, that is involved in signal transduction and regulation of actin cytoskeleton rearrangement. Because immune dysfunction in WAS may be due to an accelerated destruction of lymphocytes, we examined the susceptibility to apoptosis of resting primary lymphocytes isolated from WAS patients in the absence of exogenous apoptogenic stimulation. We found that unstimulated WAS lymphocytes underwent spontaneous apoptosis at a greater frequency than unstimulated normal lymphocytes. Coincident with increased apoptotic susceptibility, WAS lymphocytes had markedly attenuated Bcl-2 expression, whereas Bax expression did not differ. A negative correlation between the frequency of spontaneous apoptosis and the level of Bcl-2 expression was demonstrated. These data indicate that accelerated lymphocyte destruction by spontaneous induction of apoptosis may be one pathogenic mechanism by which the progressive immunodeficiency in WAS patients develops.


Subject(s)
Apoptosis , Lymphocytes/pathology , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Wiskott-Aldrich Syndrome/pathology , Adolescent , Cell Death , Child, Preschool , Humans , Infant , Lymphocytes/metabolism , Male , Wiskott-Aldrich Syndrome/metabolism
7.
J Biol Chem ; 274(9): 5564-72, 1999 Feb 26.
Article in English | MEDLINE | ID: mdl-10026172

ABSTRACT

The human MAT1 gene (ménage à trois 1) is an assembly factor and a targeting subunit of cyclin-dependent kinase (CDK)-activating kinase. The novel mechanisms by which MAT1 forms an active CDK-activating kinase and determines substrate specificity of CDK7-cyclin H are involved in the cell cycle, DNA repair, and transcription. Hyperplasia of vascular smooth muscle cells (SMC) is a fundamental pathologic feature of luminal narrowing in vascular occlusive diseases, and nothing is yet known regarding the cell cycle phase specificity of the MAT1 gene in its involvement in SMC proliferation. To investigate such novel regulatory pathways, MAT1 expression was abrogated by retrovirus-mediated gene transfer of antisense MAT1 RNA in cultured rat aortic SMCs. We show that abrogation of MAT1 expression retards SMC proliferation and inhibits cell activation from a nonproliferative state. Furthermore, we have demonstrated that these effects are due to G1 phase arrest and apoptotic cell death. Our studies indicate a link between cell cycle control and apoptosis and reveal a potential mechanism for coupling the regulation of MAT1 with G1 exit and prevention of apoptosis.


Subject(s)
Apoptosis/genetics , G1 Phase , Muscle, Smooth, Vascular/cytology , Neoplasm Proteins/genetics , RNA, Antisense/pharmacology , Animals , Aorta/cytology , Aorta/metabolism , Cells, Cultured , Gene Expression Regulation/drug effects , Muscle, Smooth, Vascular/metabolism , Rats , Transduction, Genetic
8.
Nat Med ; 4(7): 775-80, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9662367

ABSTRACT

Adenosine deaminase-deficient severe combined immunodeficiency was the first disease investigated for gene therapy because of a postulated production or survival advantage for gene-corrected T lymphocytes, which may overcome inefficient gene transfer. Four years after three newborns with this disease were given infusions of transduced autologous umbilical cord blood CD34+ cells, the frequency of gene-containing T lymphocytes has risen to 1-10%, whereas the frequencies of other hematopoietic and lymphoid cells containing the gene remain at 0.01-0.1%. Cessation of polyethylene glycol-conjugated adenosine deaminase enzyme replacement in one subject led to a decline in immune function, despite the persistence of gene-containing T lymphocytes. Thus, despite the long-term engraftment of transduced stem cells and selective accumulation of gene-containing T lymphocytes, improved gene transfer and expression will be needed to attain a therapeutic effect.


Subject(s)
Adenosine Deaminase/immunology , Antigens, CD34/immunology , Hematopoietic Stem Cell Transplantation , T-Lymphocytes/immunology , Transplantation Immunology/immunology , Adenosine Deaminase/deficiency , Adenosine Deaminase/genetics , Adenosine Deaminase/metabolism , Animals , Animals, Newborn , Cell Line , Flow Cytometry , Gene Frequency , Granulocytes/immunology , Humans , Leukocytes, Mononuclear/immunology , Lymphocyte Count , Mice , Mice, SCID , Polyethylene Glycols , T-Lymphocytes/drug effects , Transformation, Genetic , Transplantation, Autologous , Umbilical Cord
9.
Blood ; 91(11): 4145-51, 1998 Jun 01.
Article in English | MEDLINE | ID: mdl-9596660

ABSTRACT

Human hematopoietic stem cells are pluripotent, ie, capable of producing both lymphoid and myeloid progeny, and are therefore used for transplantation and gene therapy. An in vitro culture system was developed to study the multi-lineage developmental potential of a candidate human hematopoietic stem cell population, CD34+CD38- cells. CD34+CD38- cells cocultivated on the murine stromal line S17 generated predominantly CD19(+) B-cell progenitors. Transfer of cells from S17 stroma to myeloid-specific conditions ("switch culture") showed that a fraction of the immunophenotypically uncommitted CD19- cells generated on S17 stroma had myeloid potential (defined by expression of CD33 and generation of colony-forming unit-cells). Using the switch culture system, single CD34+CD38- cells were assessed for their lymphoid and myeloid potential. Nineteen of 50 (38%) clones generated from single CD34+CD38- cells possessed both B-lymphoid and myeloid potential. 94.7% of the CD34+CD38- cells with lympho-myeloid potential were late-proliferating (clonal appearance after 30 days), demonstrating that pluripotentiality is detected significantly more often in quiescent progenitors than in cytokine-responsive cells (P = .00002). The S17/switch culture system permits the in vitro assessment of the pluripotentiality of single human hematopoietic cells.


Subject(s)
Antigens, CD34/analysis , Antigens, CD , Antigens, Differentiation/analysis , Hematopoietic Stem Cells/chemistry , Lymphocytes/cytology , NAD+ Nucleosidase/analysis , ADP-ribosyl Cyclase , ADP-ribosyl Cyclase 1 , Animals , Antigens, CD19/analysis , B-Lymphocytes/cytology , Cell Differentiation , Cell Division , Cell Line , Cells, Cultured , Clone Cells , Coculture Techniques/methods , Fetal Blood , Hematopoietic Stem Cells/cytology , Humans , Immunophenotyping , Membrane Glycoproteins , Mice
SELECTION OF CITATIONS
SEARCH DETAIL
...